Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUtilico Emerging Markets Regulatory News (UEM)

Share Price Information for Utilico Emerging Markets (UEM)

Share Price is delayed by 15 minutes
Get Live Data
286.00    0.00 (0.00%)
Bid:
283.00
Ask:
286.00
Spread: 3.00 (1.06%)
Market Cap: £494.78m
UEM Live PriceLast checked at - London Stock Exchange

Intraday Utilico Emerging Markets Share Chart

UEM celebrates its 20 year anniversary

21 Jul 2025 07:00

RNS Number : 7565R
Utilico Emerging Markets Trust PLC
21 July 2025
Β 

21 July 2025

UTILICO EMERGING MARKETS TRUST PLC

(LEI Number: 2138005TJMCWR2394O39)

Β 

Utilico Emerging Markets significantly outperforms MSCI Emerging Markets Index

as it celebrates 20-year anniversary

Β 

Utilico Emerging Markets Trust plc ("UEM" or the "Company"), a UK listed investment company focused on global infrastructure and utilities megatrends in emerging markets, celebrates its 20th anniversary as a public company, having listed on the London Stock Exchange on 20 July 2005.

Β 

UEM's 20 Year anniversary highlights include:

Β· Aggregate NAV total return of 471.7%, outperforming the MSCI Emerging Markets Index, outperformance driven by decades of experience across the ICM team;

Β· The only emerging markets trust to have increased annual dividends in each of the last ten years, joining the AIC's next generation of "dividend heroes";

Β· The Portfolio Managers' enthusiasm is as strong as it has ever been about the potential for the portfolio; and

Β· This conviction is further demonstrated through the Company's long-term approach to buying back shares, being accretive to NAV and beneficial to shareholders; a total of Β£179.8m has been bought back since inception

Β 

The four global growthΒ megatrendsΒ on which the managers and their team focus are: social infrastructure, energy growth & transition, digital infrastructure and global trade. Regardless of the macro volatility and geopolitical noise, these megatrends remain fundamental in light of the infrastructure investment required for both today's needs and tomorrow's innovation.

Β 

Since inception to 30 June 2025, UEM has achieved a NAV total return of 9.1% per annum or 471.1% in aggregate, significantly outperforming the MSCI Emerging Markets Index which was up by 325.3% over that period. Despite significant macroeconomic volatility, UEM's investment strategy has also delivered significant outperformance for shareholders over the medium term. UEM's net asset value total return for the three- and five-year periods to 30 June 2025 increased by 26.9% and 54.7% respectively, significantly outperforming the MSCI Emerging Markets Index which was up by 17.2% and 25.5% respectively.

Β 

Portfolio managers Charles Jillings and Jacqueline Broers, and the ICM research team, have decades of experience in stringently researched bottom-up investing in emerging markets. Charles Jillings has been managing the trust since its IPO in 2005, and at the start of this year, ICM appointed Jacqueline Broers as joint portfolio manager alongside Charles. Jacqueline was previously deputy portfolio manager having joined ICM in 2010. The Portfolio Managers are as enthusiastic about the potential for the portfolio as they were in 2005, if not more, given the opportunities they are seeing.

Β 

Every year for the last ten years, UEM has been able to increase the annual dividend per share for shareholders, most recently, in the year to 31 March 2025, increasing distributions to 9.125p for the year, a rise of 6.1% from the previous year. This resulted in the Company joining the Association of Investment Companies' next generation of "dividend heroes", the only Global Emerging Markets trust to do so. Given the volatility of emerging market currencies and the Company's reporting currency in Sterling, this is a significant accomplishment.

Β 

The Company has been actively buying back shares, benefitting shareholders as it increases the NAV per share. Over the past 5 years to 30 June 2025, UEM bought back 40.9m shares at a cost of Β£88.8m and since inception, the Company has bought back 93.1m shares at a cost of Β£179.8m, some 34% of the current fund size.

Β 

Β 

Mark Bridgeman, Chairman of UEM said: "UEM's focus on infrastructure and utilities in emerging markets is highly differentiated from both the MSCI Emerging Markets Index and the Global Emerging Markets AIC peer group and is expertly managed by a disciplined, bottom-up approach from its Investment Manager, ICM.

Β 

"The defensive nature of UEM's infrastructure and utilities portfolio, supported by global infrastructure megatrends and the manager's disciplined stock selection, demonstrate the clear differentiation of this investment strategy. This investment approach aims to generate consistent total returns for shareholders with typically lower volatility than the index while providing an attractive dividend income.

Β 

"With President Trump's focus on tariffs, emerging markets are expected to be well placed as investors look to capitalise on this dislocation in the markets. Foreign investors are beginning to look for alternatives to the US in which to invest, which can only be positive for the asset class. With emerging markets valuations remaining relatively cheap, these markets are likely to benefit from increasing investor demand playing very well to our core investment thesis."

Β 

Β 

Charles Jillings & Jacqueline Broers, co-Portfolio Managers of UEM added: "For 20 years, UEM has focused on well researched, carefully targeted, bottom-up investing in emerging market infrastructure and utilities companies which are well placed to benefit from the global infrastructure megatrends. Whilst we have seen high levels of economic and political uncertainty, especially in recent years, we have remained focused on our investment strategy, which we believe will continue to deliver significant value for shareholders.

Β 

"This approach has remained consistent since the Company's IPO in 2005 and we are proud that over two decades our NAV and share price total returns have significantly outperformed the MSCI Emerging Markets Index.

Β 

"Emerging markets are widely expected to benefit from a rotation in investor sentiment away from the US market that is gaining momentum. Whilst macro volatility remains, this often provides investment opportunities to secure attractive long-term holdings at compelling valuations. We therefore continue to remain highly confident that the investment strategy is well placed to continue its 20-year track record of long-term outperformance."

Β 

ENDS

Β 

Name of contact and telephone number for enquiries

Β 

Montfort Communications

Gay Collins, Alex Everett +44 (0) 7798 626282

utilico@montfort.london

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAPPUMPMUPAGGU
Date   Source Headline
23rd Jun 202612:17 pmRNSNet Asset Value(s)
22nd Jun 202611:57 amRNSNet Asset Value(s)
19th Jun 20264:50 pmRNSTransaction in Own Shares & Total Voting Rights
19th Jun 202611:39 amRNSNet Asset Value(s)
19th Jun 20267:00 amRNSDividend Declaration - Special re 2025-26
19th Jun 20267:00 amRNSAnnual Financial Report
18th Jun 20264:53 pmRNSTransaction in Own Shares & Total Voting Rights
18th Jun 202612:50 pmRNSNet Asset Value(s)
17th Jun 20264:53 pmRNSTransaction in Own Shares & Total Voting Rights
17th Jun 202612:29 pmRNSNet Asset Value(s)
16th Jun 20264:59 pmRNSTransaction in Own Shares & Total Voting Rights
16th Jun 202612:02 pmRNSNet Asset Value(s)
15th Jun 202612:00 pmRNSNet Asset Value(s)
12th Jun 20265:00 pmRNSTransaction in Own Shares & Total Voting Rights
12th Jun 202611:41 amRNSNet Asset Value(s)
11th Jun 20265:06 pmRNSTransaction in Own Shares & Total Voting Rights
11th Jun 202612:43 pmRNSPublication of monthly factsheet
11th Jun 202611:52 amRNSNet Asset Value(s)
10th Jun 202611:42 amRNSNet Asset Value(s)
9th Jun 20264:45 pmRNSTransaction in Own Shares & Total Voting Rights
9th Jun 202612:04 pmRNSNet Asset Value(s)
8th Jun 202611:44 amRNSNet Asset Value(s)
5th Jun 20265:04 pmRNSTransaction in Own Shares & Total Voting Rights
5th Jun 202612:06 pmRNSNet Asset Value(s)
4th Jun 202611:48 amRNSNet Asset Value(s)
3rd Jun 20264:54 pmRNSTransaction in Own Shares & Total Voting Rights
3rd Jun 202612:37 pmRNSNet Asset Value(s)
2nd Jun 20264:46 pmRNSTransaction in Own Shares & Total Voting Rights
2nd Jun 202611:50 amRNSNet Asset Value(s)
1st Jun 20265:41 pmRNSTotal Voting Rights
1st Jun 202612:42 pmRNSNet Asset Value(s)
29th May 202611:46 amRNSNet Asset Value(s)
28th May 20264:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th May 202611:55 amRNSNet Asset Value(s)
27th May 20264:55 pmRNSTransaction in Own Shares & Total Voting Rights
27th May 202611:45 amRNSNet Asset Value(s)
26th May 20265:26 pmRNSTransaction in Own Shares & Total Voting Rights
26th May 202611:48 amRNSNet Asset Value(s)
26th May 202610:08 amRNSDividend Declaration - Q4 2025-26
22nd May 202612:44 pmRNSNet Asset Value(s)
21st May 20264:43 pmRNSTransaction in Own Shares & Total Voting Rights
21st May 202611:41 amRNSInvestor Presentation
21st May 202611:39 amRNSNet Asset Value(s)
20th May 20264:55 pmRNSTransaction in Own Shares & Total Voting Rights
20th May 202611:06 amRNSNet Asset Value(s)
19th May 202611:16 amRNSNet Asset Value(s)
19th May 20267:00 amRNSCompliance with Market Abuse Regulation
18th May 20264:59 pmRNSTransaction in Own Shares & Total Voting Rights
18th May 202612:00 pmRNSNet Asset Value(s)
15th May 20264:58 pmRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.